A Study on SANGUINATE™ for the Reduction of Delayed Graft Function in Kidney Transplant Patients
Status:
Withdrawn
Trial end date:
2018-12-01
Target enrollment:
Participant gender:
Summary
Safety and efficacy study of SANGUINATE on reduction of delayed graft function (DGF) in
patients who will be recipients of a donation after brain death (DBD) donor kidney.